參考文獻(xiàn)/References:
[1] 牛奎寧,王自,施建黨,等.胸腰椎骨折術(shù)后臥床時(shí)間及相關(guān)因素分析[J].中國(guó)骨與關(guān)節(jié)損傷雜志,2011,26(7):57-59.
[2] 李輝,徐文.創(chuàng)傷患者免疫功能與醫(yī)院感染調(diào)查[J].中華醫(yī)院感染學(xué)雜志,2001,11(4):271-273.
[3] 韓濟(jì)生.神經(jīng)科學(xué)[M].3版.北京:北京大學(xué)醫(yī)學(xué)出版社,2009:636.
[4] Schwartzberg PL,Finkelstein LD,Readinger JA,et al.Tecfamily kinase:regulators of T-helper-cell differentiation[J].Nat Rev Immunol,2005,5:284-295.
[5] Tsai YC,Won SJ,Lin MT.Effects of morpine on immune response in rats with sciatic const riction injury[J].Pain,2000,88(2):155-160.
[6] Moriishi M,Kawanishi H.Fibrin degradation products are a useful marker for the risk of encapsulating peritoneal sclerosos[J].Adv Perit Dial,2008,24:56-59.
[7] 王秀華,劉元祿,蘇姿兵,等.丹參關(guān)節(jié)內(nèi)注射對(duì)兔膝骨關(guān)節(jié)炎細(xì)胞因子IL-1及TNF的影響[J].中醫(yī)正骨,2003,15(10):1.
[8] 劉忠倫,王昌剛.中藥輔助治療脛腓骨骨折的臨床療效及對(duì)轉(zhuǎn)化生長(zhǎng)因子TGF-β1表達(dá)的影響[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志,2012,18(11):270.
[9] 劉濤,冉德洲.β活血化瘀、補(bǔ)腎益氣中藥對(duì)大鼠骨折愈合中TGF-β1的影響[J].成都體育學(xué)院學(xué)報(bào),2002,28(1):92-94.
[10] 呂紅斌,岳珍,王嘉美,等.四種中藥對(duì)體外培養(yǎng)兔關(guān)節(jié)軟骨細(xì)胞代謝的影響[J].中國(guó)運(yùn)動(dòng)醫(yī)學(xué)雜志,1995,14(3):135.
[11] 蔣海峰,宿樹蘭,歐陽(yáng)臻,等.乳香、沒(méi)藥提取物及其配伍對(duì)血小板聚集及抗凝血酶活性的影響[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志,2011,17(19):160-167.
[12] 張子理,陳蔚文.黨參、黃芪、白術(shù)提取物配伍應(yīng)用對(duì)小腸上皮細(xì)胞增殖的影響[J].廣州中醫(yī)藥大學(xué)學(xué)報(bào),2002,16(2):137-142.